Carnegie Embryology Presents: A Public Lecture on Science in the Neighborhood with Dr. Alexandria Forbes, President and CEO of clinical-stage gene therapy company MeiraGTx.

MeiraGTx focuses on the development of curative treatments for patients living with serious diseases. Their research and development efforts focus on three areas with distinct medical needs: ocular, neurodegenerative and salivary gland diseases. People who suffer from these conditions currently have treatment options ranging from none to limited; however, gene therapy has high potential to provide significant clinical benefits.

Dr. Alexandria Forbes has served as President and CEO of MeiraGtx since March 2015. Prior to joining MeiraGTx, Dr. Forbes served as Senior Vice President of Business Operations at Kadmon Holdings, Inc., a biopharmaceutical company, and has spent 12 years as an investor in the healthcare sector. at Sivik Global Healthcare and at Meadowvale Asset Management.

Prior to entering the hedge funds and biopharmaceutical industries, Dr. Forbes was a Human Frontiers/Howard Hughes postdoctoral fellow at the Skirball Institute of Biomolecular Medicine and a research fellow at Carnegie Embryology’s Spradling Lab. She holds an MSc in Natural Science from the University of Cambridge and a PhD in Molecular Genetics from the University of Oxford.